Update shared on 15 Nov 2025
Fair value Increased 4.62%Narrative Update on Medco Energi Internasional: Analyst Price Target Revision
Analysts have raised their fair value estimate for Medco Energi Internasional from Rp1,717.86 to Rp1,797.23, citing improved expectations for revenue growth, profit margins, and a lower discount rate.
What's in the News
- The Board of Directors of PT Medco Energi Internasional Tbk has authorized a buyback plan on September 4, 2025.
- PT Medco Energi Internasional Tbk (IDX:MEDC) announces a share repurchase program that will allow for up to $50 million worth of its common stock to be repurchased. This move reflects the company's commitment to delivering greater value to shareholders.
Valuation Changes
- Fair Value Estimate has increased from IDR 1,717.86 to IDR 1,797.23, reflecting a modest upward revision.
- Discount Rate has declined from 17.23% to 15.54%, which indicates a lower perceived risk or cost of capital.
- Revenue Growth Expectations have risen from 0.67x to 1.03x, signaling a more optimistic outlook on future sales expansion.
- Net Profit Margin projection increased from 16.19% to 17.40%.
- Future P/E Ratio has decreased from 10.33x to 9.37x. This suggests improved earnings prospects or a more attractive valuation.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.